BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 1757935)

  • 1. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
    Clegg DO; Williams HJ; Singer JZ; Steen VD; Schlegel S; Ziminski C; Alarcón GS; Luggen ME; Polisson RP; Willkens RF
    J Rheumatol; 1991 Sep; 18(9):1340-3. PubMed ID: 1757935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
    Bodolay E; Szegedi G
    Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
    Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
    Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases.
    Williams HJ; Alarcón GS; Neuner R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; Polisson RP; Willkens RF; Yarboro C; Morgan J; Egger MJ; Ward JR
    J Rheumatol; 1998 Feb; 25(2):261-8. PubMed ID: 9489817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
    Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
    J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors.
    Calvo-Alen J; Alarcon GS; Burgard SL; Burst N; Bartolucci AA; Williams HJ
    J Rheumatol; 1996 Mar; 23(3):469-75. PubMed ID: 8832985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
    Williams HJ; Alarcon GS; Joks R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; St Clair EW; Willkens RF; Yarboro C; Morgan JG; Egger MJ; Ward JR
    J Rheumatol; 1999 Apr; 26(4):816-25. PubMed ID: 10229402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease.
    Alarcón GS; Williams GV; Singer JZ; Steen VD; Clegg DO; Paulus HE; Billingsley LM; Luggen ME; Polisson RP; Willkens RF
    J Rheumatol; 1991 Sep; 18(9):1332-9. PubMed ID: 1757934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of common serum rheumatologic tests.
    Lane SK; Gravel JW
    Am Fam Physician; 2002 Mar; 65(6):1073-80. PubMed ID: 11925083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.
    Compagno M; Jacobsen S; Rekvig OP; Truedsson L; Heegaard NH; Nossent J; Jönsen A; Jacobsen RS; Eilertsen GØ; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(4):311-6. PubMed ID: 23496224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease.
    Conti V; Leone MC; Casato M; Nicoli M; Granata G; Carlesimo M
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):54-7. PubMed ID: 25781195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies.
    Ignat GP; Rat AC; Sychra JJ; Vo J; Varga J; Teodorescu M
    J Rheumatol; 2003 Aug; 30(8):1761-9. PubMed ID: 12913932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibodies to extractable nuclear antigen polypeptides: detection and its clinical significance].
    Xu YH
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):541-3, 573. PubMed ID: 1338517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.